BlackRock Amends Teladoc Health Stake as of Dec 31, 2023
Ticker: TDOC · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its Teladoc Health stake, showing its holdings as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership of Teladoc Health Inc. common stock as of December 31, 2023. This filing, Amendment No. 7, updates BlackRock's passive investment stake in Teladoc. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal its confidence (or lack thereof) in Teladoc's future performance, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's updated passive ownership in Teladoc Health, providing transparency on a significant institutional investor's position.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive stake in Teladoc Health, but this routine update doesn't suggest an immediate need for action. It's a data point for understanding institutional ownership.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Teladoc Health, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event which required the filing
- January 26, 2024 (date) — the date the SC 13G/A was filed
- Amendment No: 7 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 7)' sections.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company of this filing?
The subject company is Teladoc Health, Inc., as specified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc.' and 'Teladoc Health Inc (Name of Issuer)'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as stated under 'Date of Event Which Requires Filing of this Statement'.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Teladoc Health, Inc. (TDOC).